Endothelial Cell News Volume 5.25 | July 13 2020

    0
    17







    ENDOCN 5.25 | July 13 2020


    Endothelial Cell News by STEMCELL Technologies
    Vol. 5.25 – 13 July, 2020
    TOP STORY

    Generation of Functional Liver Sinusoidal Endothelial Cells from Human Pluripotent Stem-Cell-Derived Venous Angioblasts

    Investigators developed a strategy to generate liver sinusoidal endothelial cells from human pluripotent stem cells by first optimizing the specification of arterial and venous angioblasts and derivative endothelial populations.
    [Cell Stem Cell]

    AbstractGraphical Abstract

    Subscribe to Science News for free weekly science newsletters.
    PUBLICATIONSRanked by the impact factor of the journal

    Human Forebrain Endothelial Cell Therapy for Psychiatric Disorders

    Investigators generated human periventricular endothelial cells, using human pluripotent stem cell technology, and extensively characterized its molecular, cellular, and functional properties.
    [Molecular Psychiatry]

    Full Article

    Endosomal Escape of Polymer‐Coated Silica Nanoparticles in Endothelial Cells

    Primary human endothelial cells are exposed to controlled concentrations of polymer‐functionalized silica nanoparticles to induce lysosomal damage and achieve cytosolic delivery.
    [Small]

    Abstract

    Focal Adhesion Displacement Magnitude Is a Unifying Feature of Tensional Homeostasis

    Micropattern traction microscopy was used to study a wide range of focal adhesion traction forces generated by bovine vascular smooth muscle cells and bovine aortic endothelial cells cultured on substrates of stiffness of 3.6, 6.7, 13.6, and 30 kPa.
    [Acta Biomaterialia]

    Abstract

    Cancer-Associated Fibroblasts Mediate Cancer Progression and Remodel the Tumoroid Stroma

    Cancer-associated fibroblasts enhanced the distance and surface area of the invasive cancer mass whilst inhibiting vascular-like network formation. These processes correlated with the upregulation of hepatocyte growth factor, metallopeptidase inhibitor 1 and fibulin-5.
    [British Journal of Cancer]

    Abstract

    Thrombin Is a Therapeutic Target for Non-Small-Cell Lung Cancer to Inhibit Vasculogenic Mimicry Formation

    Researchers found that vasculogenic mimicry (VM) was associated with the overall survival of non-small-cell lung cancer patients, and that thrombin expression was closely related to VM formation.
    [Signal Transduction and Targeted Therapy]

    Full Article

    Prostaglandin E2 Breaks Down Pericyte–Endothelial Cell Interaction via EP1 and EP4-Dependent Downregulation of Pericyte N-Cadherin, Connexin-43, and R-Ras

    Scientists showed that the exposure to Prostaglandin E2 switched pericytes to a fast-migrating, loosely adhered phenotype that failed to intimately interact with endothelial cells.
    [Scientific Reports]

    Full Article

    Doxorubicin-Loaded Iron Oxide Nanoparticles for Glioblastoma Therapy: A Combinational Approach for Enhanced Delivery of Nanoparticles

    The doxorubicin (DOX) loaded ethylenediamine triacetic acid-iron oxide nanoparticles released DOX within four days with the capability of an accelerated release in acidic microenvironments.
    [Scientific Reports]

    Full Article

    Glomerular Endothelial Cell Heterogeneity in Alport Syndrome

    Scientists characterized glomerular endothelial cells from wild type and col4α5 knockout Alport syndrome mice, a hereditary disorder characterized by progressive renal failure.
    [Scientific Reports]

    Full Article

    326522fe-ef88-40f1-a657-637149f2f23b_ON808MSC-EC-Cult-645x100-CXN
    REVIEWS

    Extrapulmonary Manifestations of COVID-19

    The authors review the extrapulmonary organ-specific pathophysiology, presentations and management considerations for patients with COVID-19.
    [Nature Medicine]

    Full Article

    INDUSTRY AND POLICY NEWS

    Merck and Eisai Receive Complete Response Letter for KEYTRUDA (Pembrolizumab) plus LENVIMA® (Lenvatinib) Combination as First-Line Treatment for Unresectable Hepatocellular Carcinoma

    Merck and Eisai announced that the FDA has issued a complete response letter regarding Merck’s and Eisai’s applications seeking accelerated approval of KEYTRUDA, Merck’s anti-PD-1 therapy, plus LENVIMA, the orally available multiple receptor tyrosine kinase inhibitor discovered by Eisai, for the first-line treatment of patients with unresectable hepatocellular carcinoma.
    [Merck, Inc.]

    Press Release

    ‘I Feel Like I Am Not Welcome’: Medical, Doctoral Students from Abroad Grapple with Uncertainty from New ICE Rules

    International students completing their medical and doctoral degrees in the US are wrestling with frustration and uncertainty following the release of federal rules this week that could bar them from staying in the country.
    [STAT News]

    Editorial

    ‘Disturbing and Cruel.’ Universities Blast New Visa Rule for International Students

    A new US immigration policy, which threatens to revoke visas for certain international students if they are not taking in-person classes, is stirring panic and confusion and causing some universities to push back with lawsuits.
    [Science]

    Editorial

    FEATURED EVENT

    2020 Parenteral Drug Association (PDA) Annual Meeting

    July 20 – July 22
    Virtual

    > See All Events

    JOB OPPORTUNITIES

    Senior Postdoctoral Research Fellow – Molecular Mechanisms of Viral Pathogenesis

    Beth Israel Deaconess Medical Center – Boston, Massachusetts, United States

    Professor – Endothelial Cell Biology

    Universitätsklinikum Bonn – Bonn, Germany

    Postdoctoral Fellow – Endothelial Cells in the Blood-Brain Barrier

    The University of Texas Health Science Center at Houston – Houston, Texas, United States

    Research Fellow – Endothelial and Cardiomyocyte Remodeling in Insulin Resistance

    Queen’s University Belfast – Belfast, United Kingdom

    Postdoctoral Fellow – Non-Coding RNAs in Vascular Disease

    The Brigham and Women’s Hospital – Boston, Massachusetts, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Endothelial Cell News Twitter